An interventional study of Initial periodontal therapy in Chronic Periodontitis, Generalized and Smoking ( Cigarette), sponsored by Marmara University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Marmara University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Chronic Periodontitis with a site in Turkey — 1 open to participants now, 1 under way, none of them phase 3. Chronic Periodontitis · Turkey.
Among the 26 studies in Chronic Periodontitis with a site in Turkey, this one is the 5th largest by enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2016, is one of 12 with no phase, and was the 26th registered.
378 studies on the registry are indexed under Chronic Periodontitis; 21 are open to participants now.
Browse Chronic Periodontitis studies →1 of the 26 studies in Chronic Periodontitis with a site in Turkey is open now. Recruiting first, the newest first:
Hacettepe University · Sites in Turkey
Ages 18–65
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 13 Chronic Periodontitis studies recruiting now, 7 (54%) set no upper age limit and 5 (38%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 2 started in 2016.
This study's enrollment of 40 is below the median of 46 across 308 interventional studies indexed under Chronic Periodontitis.
Median enrollment 30 across the 15 interventional studies, 73 across the 11 observational. Of the 25 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 26 has an industry lead sponsor. The 10 most frequent:
Marmara University is the lead sponsor of 601 studies on the registry; 137 are open to participants now.
Marmara University has 4 studies filed under Chronic Periodontitis — fewer than ten, so there is no comparison to draw.
1 of the studies in Chronic Periodontitis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07452640Hacettepe UniversityVector® System vs Mini-Five Curettes in Non-Surgical Periodontal Therapy | 2027-02 |
Add it to your calendar (.ics) → With an account.
Among the 26 studies in Chronic Periodontitis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study was conducted to evaluate the effect of initial periodontal treatment on clinical parameters, gingival crevicular fluid (GCF) volume, cotinine levels and tissue factor (TF) activity in saliva and GCF in smoker and non-smoker patients with chronic periodontitis. Forty systemically healthy patients with chronic periodontitis (20 smokers, 20 non-smokers) were included. Initial periodontal treatment consisting of oral hygiene instruction, scaling and root planing was applied. Clinical measurements were recorded and saliva and GCF samples were collected at baseline and 1 and 3 months after treatment.
Smoking is considered a major environmental risk factor for periodontitis and is known to impair the response to periodontal therapy. Cotinine, the main metabolite of nicotine, is regarded as a reliable biochemical marker of smoking status. Tissue factor (TF), the initiator of the extrinsic coagulation pathway, has been detected in saliva and is thought to contribute to hemostasis and the barrier function of the oral mucosa.
Patients diagnosed with chronic periodontitis according to the 1999 AAP classification were allocated into two groups according to smoking status: smokers (≥10 cigarettes/day for the last 5 years, n=20) and non-smokers (n=20). One day before treatment (day -1), plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL) and bleeding on probing (BOP) were recorded at six sites per tooth with a UNC-15 probe, and intraoral photographs were taken. On day 0, unstimulated saliva samples were collected, and GCF samples were obtained with paper strips from sites with PD ≥5 mm. GCF volume was determined by weighing. Oral hygiene instruction (modified Bass technique, dental floss/interdental brushes) was then given, and full-mouth supragingival scaling was performed. Subgingival scaling and root planing were carried out under local anesthesia with ultrasonic scalers and Gracey curettes, one quadrant per weekly session over 4 sessions. Clinical measurements and saliva/GCF sampling were repeated at 1 and 3 months. All measurements, sample collections and treatments were performed by the same investigator. TF activity was analyzed with the Quick method (clotting time), and cotinine levels were determined by competitive ELISA. Sample size was calculated based on a between-group GI difference of 0.3 (SD 0.2), with α=0.05 and 95% power; 12 patients per group were found to be required, and 20 patients per group were enrolled to allow for possible dropouts.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Smoker patients with chronic periodontitis who received initial periodontal therapy.
Procedure: Initial periodontal therapy
Non-smoker patients with chronic periodontitis who received initial periodontal therapy.
Procedure: Initial periodontal therapy
Oral hygiene instruction and full-mouth scaling and root planing performed with ultrasonic scalers and Gracey curettes under local anesthesia in 4 sessions.
Change in Gingival Index
Time frame: baseline, 1 month, 3 months
Salivary cotinine (ng/ml)
Time frame: baseline, 1 month, 3 months
GCF cotinine (ng/ml)
Time frame: baseline, 1 month, 3 months
Salivary TF activity (clotting time, s)
Time frame: baseline, 1 month, 3 months
GCF TF activity (clotting time, s)
Time frame: baseline, 1 month, 3 months
Plan to share: No — Individual participant data will not be shared, as data sharing was not included in the informed consent obtained from participants.
No publications or documents are linked to this record.
Ran from Nov 2016 to primary completion in May 2017, 5 months.
Of 89 non-industry interventional studies with no phase under Chronic Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 24. This study's 5 months is below that.
Counting every sponsor, half of 90 studies reached it within 15 months; a quarter within 10 and three quarters within 24.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.